SYNAPSE Austria: Ten research institutions turn biomedical discovery into therapies and start-ups
Ten Austrian research institutions have announced SYNAPSE Austria, a joint platform to help move life science discoveries from academic research towards new medicines, medical technologies and start-ups.The platform will bring together expertise, facilities and external networks distributed across the partner institutions. Its work will focus on four areas: connecting expertise and facilities; jointly assessing projects for translational…
How our blood vessels age from within
To uncover how endothelial cells, the inner linings of blood vessels, change over the course of a lifespan, an international research team led by Laura de Rooij at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences has created the Human Aging Endothelial Cell Atlas, the first comprehensive atlas of vascular aging. By analyzing gene activity data from more than 375,000 human cells across 290 samples and 12 tissues,…
CeMM congratulates the MedUni Vienna on the opening of two new building!
CeMM warmly congratulates the Medical University of Vienna and the Vienna General Hospital on the opening of their Center for Translational Medicine and the Eric Kandel Institute! On 1 and 2 October 2026, the Medical University of Vienna and its University Hospital (AKH Wien) opened two new research buildings at the MedUni Campus AKH: the Center for Translational Medicine (CTM) and the Eric Kandel Institute – Center for Precision Medicine…
From autism to Alzheimer’s: Membrane transporters open new avenues for treating brain disorders
Solute carriers (SLCs) are specialized transport proteins that control the movement of nutrients, ions and neurotransmitters across cell membranes and are essential for brain metabolism and neuronal communication. While some SLCs have been targeted successfully by drugs for decades, most of this large protein family remains therapeutically unexplored. A new review in Nature Reviews Drug Discovery (DOI: 10.1038/s41573-026-01513-4; impact factor:…
Tiny molecular rings open new ways for designing better medicines
A small change in a molecule can make a big difference in how it behaves in the human body. Researchers at the University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna have now developed a simple and versatile way to make so-called “aminocyclopropanes” – compounds based on tiny, triangular structures to fine-tune the properties of biologically active molecules and…
To complement the CeMM Faculty, we are looking for Adjunct Principal Investigators in pain/nociception research
CeMM, Vienna is seeking international partner research institutes to collaborate on Pain/Nociception and Human Aging/Healthy Lifespan Expansion. We offer an initial 5-years collaboration contract, an Adjunct PI package of € 75.000 per year, including a fully equipped laboratory, 1 PhD Student salary, consumables, facility services and travel expenses, and support in the successful securement of extra funds to recruit additional team members.
Organs age at different speeds: a blood test might soon tell which ones
AI-based “tissue clocks” can estimate the biological age of human organs from histological images, researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Ludwig Boltzmann Institute for Network Medicine (LBI-NetMed) at the University of Vienna showed. By analyzing more than 25,000 tissue samples across 40 tissue types, their study reveals that organs age at different rates throughout life and…
A New Layer of Control for a Decades-Old Leukemia Drug
How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led by researchers from CeMM and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity. Published in Nature Communications (DOI 10.1038/s41467-026-74489-9), the findings combine targeted protein degradation, medicinal chemistry and genetic experiments to…
Invisible threads: how our environment quietly shapes disease
From the air we breathe to the food we eat, we are constantly exposed to thousands of chemicals – yet how these exposures affect our health has remained surprisingly difficult to understand. A new study led by researchers at CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Ludwig Boltzmann Institute for Network Medicine of the Ludwig Boltzmann Gesellschaft at the University of Vienna, published in Nature…
Georg Winter elected as EMBO Member
CeMM warmly congratulates Georg Winter, AITHYRA Scientific Director and CeMM Adjunct Principal Investigator (both institutes of the Austrian Academy of Sciences), on his election to the Membership of the European Molecular Biology Organization (EMBO). This year, 71 leading life scientists from 23 countries were elected to the EMBO Membership in recognition of their outstanding research achievements and scientific leadership. Georg Winter is…
Mechanism of leukemia predisposition unraveled
Spontaneous genetic mutations can disrupt normal blood development and drive pediatric leukemia. In addition to these acquired mutations, inherited genetic variants can also increase leukemia risk, but the underlying molecular mechanisms remain poorly understood. A new study from the group of CeMM Adjunct PI and St. Anna CCRI PI Davide Seruggia reveals how the protein ARID5B controls gene expression to safeguard B cell development and how genetic…
Christoph Bock receives ERC Advanced Grant to engineer “living drugs” for cancer therapy
Christoph Bock, Principal Investigator at CeMM and Professor of Medical Informatics at the Medical University of Vienna, has been awarded an ERC Advanced Grant by the European Research Council (ERC). With €2.5 million in grant funding from the European Union, the Solid-CART project seeks to develop stronger and smarter CAR T cells as immunotherapy for solid tumors. With this new grant, Christoph Bock has now received an ERC Starting,…
Christoph Bock contributes to Horizon Europe consortium investigating melanoma risk in young adults
CeMM Principal Investigator and Medical University Professor Christoph Bock is part of the newly funded Horizon Europe Mission Cancer project PhotoMel, an international consortium investigating how early-life UV light exposure and skincare additives contribute to skin cancer (melanoma) in young adults. Coordinated by the Medical University of Vienna, the project brings together leading experts in dermatology, molecular biology, imaging,…
Clarissa Campbell appointed Tenure-Track Professor at the University of Vienna
CeMM congratulates Clarissa Campbell on her appointment as Tenure-Track Professor of Immunobiology at the University of Vienna. At CeMM, Clarissa Campbell will remain affiliated as Adjunct Principal Investigator. Her research group will be located at CeMM until the end of the year. Clarissa Campbell has been a Principal Investigator at CeMM since 2021, where she established an internationally recognized research group at the intersection of…
Giulio Superti-Furga appointed Founding Director of Graz-based CORI Institute
CeMM warmly congratulates its founding director, Giulio Superti-Furga, on his appointment as the scientific founding director of the newly established CORI Institute for Metabolism Research in Graz! The new institute was created through a unique partnership between the Austrian Academy of Sciences, the University of Graz, the Medical University of Graz, and the Graz University of Technology. CORI aims to become one of Europe’s leading…
